About
Gene-Eden-VIR and Novirin clear the HPV virus (see published clinical study here)
Gene-Eden-VIR and Novirin decrease and even stop the genital and oral herpes outbreaks caused by the herpes virus (see clinical studies here, here, and here, and details below). †
Gene-Eden-VIR and Novirin are safe (see here)
The ingredients of Gene-Eden-VIR and Novirin are all natural.
Gene-Eden-VIR and Novirin come in a capsule taken orally.
Gene-Eden-VIR and Novirin target the latent HPV (Human Papillomavirus)
Gene-Eden-VIR and Novirin target the latent herpes virus (HSV1 and HSV2). †
Gene-Eden-VIR and Novirin come with a 90 Days Money-Back Guarantee.
The Gene-Eden-VIR and Novirin formula was developed by analyzing thousands of scientific studies using artificial intelligence (AI).
Gene-Eden-VIR was launched at the end of 2009, and Novirin in 2014.
You can choose to take either Gene-Eden-VIR or Novirin. There is no need to take both treatments at the same time.
Why take Gene-Eden-VIR or Novirin?
Since clinical studies showed that Gene-Eden-VIR/Novirin decrease and even stop the herpes outbreaks. The studies also showed that Gene-Eden-VIR/Novirin is safer and more effective than acyclovir, valacyclovir, and famciclovir, the three leading drugs used in the treatment of genital herpes. A clinical study showed that Gene-Eden-VIR/Novirin clears the human papillomavirus (HPV). The clinical study was conducted by Dr. Hanan Polansky, Dr. Edan Itzkovitz, and Adrian Javaherian from the Center for the Biology of Chronic Disease (CBCD). The study was published in the leading medical journal Drug Design, Development and Therapy. The study is listed on Pubmed, the most selective and prestigious database of medical papers in the world. Pubmed is developed and maintained by the National Center for Biotechnology Information (NCBI), at the U.S. National Library of Medicine (NLM), located at the National Institutes of Health (NIH). Such listing indicates that the clinical studies are of high quality and can be trusted in making decisions about your health. *†
What are Gene-Eden-VIR and Novirin?
Gene-Eden-VIR and Novirin are patented herbal treatments for HPV. Gene-Eden-VIR and Novirin are unique treatments developed by our own scientists. The patented formula of both treatments includes 100 mg of a quercetin extract, 150 mg of a green tea extract, 50 mg of a cinnamon extract, 25 mg of a licorice extract, and 100 mcg of selenium. Gene-Eden-VIR was launched at the end of 2009, and Novirin in 2014. The difference between the two products is that Novirin has higher quality, more expensive ingredients. *†
In addition to Gene-Eden-VIR and Novirin, what other treatments clear the virus?
There are no approved drugs that clear the human papillomavirus (HPV), or stop the abnormal growths. However, there are vaccines, which are given to uninfected individuals, usually young girls and boys, to boost their immune system against the virus. There are also surgical procedures that doctors use to remove warts and precancerous and cancerous cells caused by the virus. These procedures include cryotherapy, conization, and the Loop Electrosurgical Excision Procedure (LEEP). However, these procedures only remove abnormal growths. They don’t kill the virus in the body. They also don’t prevent the virus from causing new growths. As a result, many cases of HPV infection require lifelong monitoring, and repeated expensive and painful procedures. The three leading drugs against genital herpes are acyclovir (Zovirax), famciclovir (Famvir), and valacyclovir (Valtrex). Acyclovir was approved by the US Food and Drug Administration (FDA) in 1984, valacyclovir in 1995, and famciclovir in 1994. All drugs are used in both episodic and suppressive treatment of the disease. In episodic treatment the patient administers the drug during outbreaks. The main objective of episodic treatment is to decrease the duration of the outbreaks, that is, the time it takes the sores to heal. Clinical studies showed that episodic treatment with these drugs decease the time it takes a sore to heal by 1–2 days. In suppressive treatment the patients take the drugs daily, that is, even when there are no outbreaks. The most common objective of suppressive treatment is to decrease the number of outbreaks. Clinical studies showed that suppressive treatment with these drugs for a period of 4-12 months decreases the number of outbreaks such that about 50% of the patients have no outbreaks during the treatment, and the other 50% have a 70%–80% decrease in the number of their outbreaks. *†*†